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ABSTRACT
Fc Gamma Receptor 3B (FcyRIIIB, encoded by the gene FCGR3B) plays a crucial 
role in immunity triggered by cellular effector and regulatory functions. Copy number 
variation (CNV) of this gene has been previously reported to affect susceptibility to 
several autoimmune diseases and chronic inflammatory conditions. However, it 
remains a challenge to accurately determine the copy number of this gene in different 
individuals. Thus this study aimed to establish the most robust CNV genotyping assay 
by comparing the accuracy and efficiency of (i) quantative PCR (qPCR), (ii) 
Sequenom Mass ARRAY, and (iii) Paralogue Ratio Test-Restriction Enzyme Digest 
Variant Ratio (PRT-REDVR). Subsequently the distribution of FCGR3B CNV among 
the dengue patients in Malaysia was characterized and its association with the severity 
of the disease was determined. A total of 237 samples were recruited from various 
study hospitals, of which 191 samples were included into further experiments. 120 
were clinically diagnosed as severe dengue or warning sign, while 71 were dengue 
fever (DF). In the comparison of the three CNV genotyping assays, qPCR showed a 
considerably broader distribution of signal intensity compared to the other assays, 
potentially introducing error in estimation of copy number. Both Sequenom and PRT- 
REDVR showed lesser systematic bias, and estimate copy number within the correct 
range, although PRT-REDVR appears to be more precise and accurate method when 
genotype FCGRSB. Collectively PRT-REDVR was considered to be most appropriate 
in the study of multiallelic CNV of FCGR3B. Multiple independent assays should be 
considered to accurately genotype the CNV of FCGR3B. In the second part of the 
study, 168 dengue samples (108 case, defined as dengue patients with signs of 
vascular leakage, and 60 control, defined as dengue patients without vascular leakage) 
and 52 of healthy samples genotyped with PRT-REDVR were included in the genetic 
association study. The analysis revealed statistical significance between CNV of 
FCGR3B of control, case and dengue sample against CNV of FCGR3B of healthy 
sample, respectively (p = 0.012, p = 0.007 and p = 0.012). On the other hand, there is 
no significance association shows between case and control (p = 0.301). However, a 
trend towards the low copy number (CN <2) in case was observed, hence postulating 
that lower copy number may be attributed with vascular leakage in dengue. Larger 
number of samples however, is needed to address this postulation.
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CHAPTER ONE 
INTRODUCTION
1.1 BACKGROUND
Dengue is a significant threat to the public health worldwide nowadays. The 
dengue virus is transmitted to humans by infected mosquitoes, mainly by Aedes aegypti 
and Aedes albopictus. Dengue virus belongs to the genus of Flavivirus, family Flaviridae 
(Shekhar, 1992), and consists of four serotypes: DENV1, DENV2, DENV3, and DENV4 
(Noisakran and Pemg, 2008; Lin et al., 2006). DENV has a single stranded RNA genome 
approximately 11 kb in length, comprising of three structural protein genes, encoding the 
Core (C), Membrane (M), and Envelope (E) and seven non-structural (NS) proteins: NS1, 
NS2a, NS2b, NS3, NS4a, NS4b, and NS5 (Kurane, 2007).
Any of the four dengue virus serotypes could result in dengue fever (DF), an acute 
viral infection with typical symptoms of fever, rash, headache, muscle and joint pain. 
Occasionally, DF may progress to dengue hemorrhagic fever (DHF), a potentially life- 
threatening illness associated with vascular leakage, hemorrhage and shock (WHO, 
1997).
Approximately 50-100 million cases of severe dengue requiring hospitalization 
have been reported, of which, approximately 500 000 resulted in dengue hemorrhagic 
fever (DHF) or Dengue Shock Syndrome (DSS), causing more than 20 000 death 
worldwide (WHO, 2009). Dengue is endemic in more than 100 countries including 
Southeast Asia, the Caribbean and South Pacific regions, South and Central America; 
DHF/DSS in more than 60 countries (WHO DengueNet report, 2005).
It has been an important and major public health concern in Malaysia ever since 
its detection in 1902 (Azami et al., 2011). The incidence rate of dengue in year 2011 was
63.6 per 100 000 populations (Ministry of Health Malaysia, 2011). Dengue is no longer a 
predominantly urban disease as it has expanded geographically into the rural areas. 
Azami et al. (2011) also revealed that there was not much difference in the dengue IgG
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